How cells 鈥榙rink鈥� and what that could mean for cancer treatment

A woman in a white lab coat stands in front of a whiteboard, talking with students.
Natalie Thiex works with undergraduate and graduate students in her 蘑菇传媒 lab.

There鈥檚 something basic about how the cells in your body work that the scientific community doesn鈥檛 fully understand.

It鈥檚 called macropinocytosis. That鈥檚 an important process by which cells take in nutrients and other molecules from the fluids around them.

Macropinocytosis has barely been studied. But in a lab tucked away in 蘑菇传媒鈥檚 Avera Health and Science Center, a research team is making breakthroughs.

Natalie Thiex is a graduate coordinator of the human biology master鈥檚 program and a cell biology researcher at SDSU.

鈥淚 think people would be surprised when they find out just how little we know about how macropinocytosis works,鈥� she said.

Thiex and her lab team received a $2 million R01 grant from the National Institutes of Health to fill in those gaps. It鈥檚 research that could have wide-ranging applications, including for cancer treatment and basic immune function.

Cell drinking vs. eating

In the human body, cells can take up the fluid around them while they float in the bloodstream or in a tissue.

Thiex refers to it as 鈥渃ell drinking.鈥� With macropinocytosis, the cells slurp up a lot.

鈥淥ne of my graduate students would put up a picture of a 7-Eleven Big Gulp on his presentations to get the idea across,鈥� she said.

When macrophages, a type of white blood cell, drink something up from the environment around them, they take a big gulp.

鈥淭hey are taking up nutrients and removing debris or maybe even clearing up inflammation,鈥� Thiex said.

Macrophages are the first responders of the body鈥檚 immune system. They鈥檙e most famous for phagocytosis 鈥� a process by which they 鈥渆at鈥� and neutralize an invading pathogen.

Phagocytosis is better understood. A receptor on the cell鈥檚 surface binds to a target and identifies it as something that needs to be removed. The cell鈥檚 membrane envelops the target and brings it and a fluid-filled bubble into the cell where it can be digested. Phagocytosis involves taking in solid particles and is cell eating instead of drinking.

With macropinocytosis, scientists have no idea how a cell knows there鈥檚 something in the surrounding fluid that would be good to drink.

鈥淚t happens spontaneously, and some cells like macrophages do it all the time,鈥� Thiex said.

It鈥檚 especially surprising since macropinocytosis takes a lot of orchestration within a cell. The cell structure pushes up the membrane from below, creating ruffles on the cell鈥檚 surface. The ruffles collapse and capture a bubble of fluid 鈥� called a macropinosome 鈥� and bring it into the cell.

鈥淲e are very curious to know how a cell organizes its membrane like that without any target to scaffold it.鈥� she said.

Up to now, it was assumed macrocytosis was a different version of phagocytosis, but an experiment in the Thiex lab shows that鈥檚 not true.

Glowing answers

It starts with guide RNA and a special protein called Cas9. The lab can essentially order a tiny, 15-microliter tube filled with 80,000 different guide RNAs. Those target different parts of the genome.

鈥淲e have a dish of macrophages in a culture, and each cell has a different gene disruption in it. We don鈥檛 know which has which gene disruption, but we do know that if it happens to be critical to macropinocytosis, we expect the cell to not be able to make a macropinosome very efficiently,鈥� she said.

The lab then splashes the dish with a fluorescent dye and waits 30 minutes. Thiex or a lab worker will wash off the excess dye and sort the cells by how fluorescent they are. The cells that can鈥檛 perform macropinocytosis very well will have low fluorescence, meaning they didn鈥檛 drink up much of the dye around them.

A computer screen displaying images of green and purple cells.
Images of cells that have drunk fluorescent dye.

鈥淲e can sort the low drinkers into one tube and the high fluorescent cells into another one. So those low drinkers, they would be the cells that have genes disrupted that are required for macropinocytosis,鈥� she said.

The lab then analyzes the low drinkers to see which guide RNAs they were impacted by and which genes those guide RNA disrupted. That can provide a clue as to which parts of the genome control macropinocytosis.

Three new discoveries

The Thiex lab has already busted through a few assumptions held by the larger scientific community. First, the solute many people were using to study macropinocytosis was actually being taken into the cell through a different process, not macropinocytosis.

鈥淭hat鈥檚 probably one of the reasons why people weren鈥檛 able to get much traction understanding the macropinocytosis process, especially in macrophages,鈥� Thiex said.

Second, macropinocytosis doesn鈥檛 use the same genes to work as phagocytosis. In fact, they鈥檝e found that some of the machinery used to activate phagocytosis actually inhibits macropinocytosis.

And lastly, the lab identified a lipid in the cell membrane that seems to play a big role in macropinocytosis. With the R01 grant, the Thiex Lab will further investigate the PI3P lipid and how it works.

Not only could this research build a foundational understanding of how cells work, but it could also be a new pathway for disease treatments.

A student works in a lab space.
A student working in the Thiex lab.

Thiex said cancer cells need a lot of nutrients to support their rapid, out-of-control growth. To take in a lot of nutrients, these cells kick macropinocytosis into high gear.

Understanding macropinocytosis means researchers could learn how to inhibit it and stop cancer cell growth. It could also help prevent other out-of-control reactions in the human body, such as during an autoimmune attack.

鈥淪ometimes, you don鈥檛 know how your research is going to be useful, but almost all of our medical knowledge has come from somebody just trying to figure out how cells work. Almost every new medicine comes from understanding a basic molecular process and then figuring out a way to inhibit or force it,鈥� Thiex said.

The R01 grant will fund the lab for four years, including the salaries of graduate and undergraduate students gaining hands-on experience performing these experiments.

鈥淚t will help us finish our research and experiments related to this topic and then publish and disseminate the knowledge we learned to the whole world,鈥� Thiex said. 

Starting on the COBRE launchpad

Thiex was one of the original research project leaders for SDSU鈥檚 Center of Biomedical 蘑菇传媒 Excellence, or COBRE, called BioSNTR II and funded by the National Institutes of Health.

Daniel Scholl is the vice president for research and economic development at SDSU.

鈥淭he NIH COBRE Center, BioSNTR II, has been a tremendously effective development program for SDSU faculty,鈥� he said. 鈥淣atalie Thiex's new NIH-funded work on how cells behave will help scientists better understand how to identify and treat diseases. BioSNTR II provided an opportunity, and Dr. Thiex built on it.鈥� 

SDSU is the only educational institution in South Dakota with one of these centers.

鈥淐OBRE helps faculty members with an on-ramp into research. They can build up their labs and research capacity and get key publications out,鈥� said Adam Hoppe, an SDSU professor and the associate dean of research in the College of Natural Sciences.

From the research and publications supported by the COBRE, Thiex and other former project leaders have gone on to receive R01 grants. 

鈥淩01 grants are sort of a membership card for biomedical research. It shows high research performance and the scale of their work. You鈥檙e running a really strong research lab,鈥� Hoppe said.

Thiex is now the third SDSU COBRE researcher to receive an R01 grant. There are several current SDSU researchers performing research under COBRE, so she won鈥檛 be the last.

Republishing

You may republish SDSU News Center articles for free, online or in print. Questions? Contact us at sdsu.news@sdstate.edu or 605-688-6161.

Related Areas